Marshall Wace North America’s Sanofi SNY Stock Holding History

Marshall Wace North America’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$506K	Buy	+10,499	New	+$534K	﹤0.01%	1119
2021 Q1	–	Sell	-36,142	Closed	-$1.76M	–	1760
2020 Q4	$1.76M	Buy	36,142 +29,787	+469%	+$1.47M	0.01%	792
2020 Q3	$319K	Sell	6,355 -48,559	-88%	-$2.5M	﹤0.01%	1057
2020 Q2	$2.8M	Buy	+54,914	New	+$2.67M	0.02%	493
2020 Q1	–	Sell	-27,439	Closed	-$1.38M	–	1575
2019 Q4	$1.38M	Buy	+27,439	New	+$1.29M	0.01%	653
2018 Q3	–	Sell	-21,976	Closed	-$879K	–	1335
2018 Q2	$879K	Sell	21,976 -368,405	-94%	-$14.5M	0.01%	962
2018 Q1	$15.6M	Buy	390,381 +351,005	+891%	+$14.6M	0.08%	294
2017 Q4	$1.69M	Buy	+39,376	New	+$1.82M	0.01%	875

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Marshall Wace North America's SNY Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Sanofi (SNY) in Q3 2021: 10,499 shares worth $506K. The stake represents ﹤0.01% of the portfolio and ranks #1119 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in SNY as recently as Q4 2020.

Marshall Wace North America first reported a position in SNY in Q4 2017 and has held it in 8 quarters since. The position peaked at $15.6M in Q1 2018. 577 funds tracked by Wall St. Rank hold SNY as of Q3 2021.

Marshall Wace North America held 10,499 shares of Sanofi worth $506K as of Q3 2021.
Sanofi was a new Marshall Wace North America position in Q3 2021.
Sanofi made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1119 holding.
Marshall Wace North America first reported a position in Sanofi in Q4 2017 and has held it in 8 quarters since.
Marshall Wace North America's Sanofi position peaked at $15.6M in Q1 2018.
577 funds tracked by Wall St. Rank held Sanofi as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.